成人创伤患者酒精和药物筛查实施的医院间差异
这项回顾性观察性横断面研究基于创伤质量改进计划(TQIP)2017-2018年数据,纳入18岁及以上创伤患者1,282,111例、744家医院,采用分层多因素logistic回归控制患者和医院变量,评估酒精和药物筛查的医院间差异。结果显示,619,423例(48.3%)接受了酒精筛查,388,732例(30.3%)接受了药物筛查;医院层面酒精筛查率范围0.8%-99.7%(均值42.4%,SD 25.1%),药物筛查率范围0.2%-99.9%(均值27.1%,SD 20.2%)。酒精筛查方差37.1%(95%CI 34.7-39.6%)、药物筛查方差31.5%(95%CI 29.2-33.9%)归因于医院层面;I/II级创伤中心酒精筛查调整比值比(aOR)1.31(95%CI 1.22-1.41)、药物筛查aOR 1.16(95%CI 1.08-1.25),均高于III级和非创伤中心。作者认为,推荐筛查的执行率总体偏低且医院间差异显著,提示存在改善创伤患者救治、降低物质使用和创伤再犯率的机会。
要点
- TQIP 2017-2018年744家医院1,282,111例成人创伤患者中,酒精筛查率48.3%(619,423例),药物筛查率30.3%(388,732例)。
- 医院层面酒精筛查率从0.8%到99.7%(均值42.4%,SD 25.1%),药物筛查率从0.2%到99.9%(均值27.1%,SD 20.2%)。
- 酒精筛查方差的37.1%(95%CI 34.7-39.6%)和药物筛查方差的31.5%(95%CI 29.2-33.9%)位于医院层面。
- I/II级创伤中心酒精筛查aOR 1.31(95%CI 1.22-1.41)、药物筛查aOR 1.16(95%CI 1.08-1.25),高于III级和非创伤中心。
- 调整后识别出酒精低筛查医院297家、高筛查医院307家,药物低筛查医院298家、高筛查医院298家。
适用人群与场景
- 创伤质量改进计划(TQIP)2017-2018年登记的18岁及以上创伤患者,共1,282,111例,来自744家医院。
研究设计与关键结果
- 研究类型:回顾性观察性横断面研究,基于创伤质量改进计划(TQIP)2017-2018年数据,纳入18岁及以上创伤患者1,282,111例、744家医院。
- 酒精筛查619,423例(48.3%),药物筛查388,732例(30.3%);医院层面酒精筛查率范围0.8%-99.7%(均值42.4%,SD 25.1%),药物筛查率范围0.2%-99.9%(均值27.1%,SD 20.2%)。
- 酒精筛查方差37.1%(95%CI 34.7-39.6%)和药物筛查方差31.5%(95%CI 29.2-33.9%)位于医院层面。
- I/II级创伤中心较III级和非创伤中心酒精筛查aOR 1.31(95%CI 1.22-1.41)、药物筛查aOR 1.16(95%CI 1.08-1.25)。
- 调整患者和医院变量后,酒精筛查低筛查医院297家、高筛查医院307家;药物筛查低筛查医院298家、高筛查医院298家。
证据类型、等级与局限
- 证据类型:回顾性观察性横断面研究;证据等级:预后与流行病学,Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,推荐酒精和药物筛查的执行率总体偏低且医院间差异显著,这凸显了改善创伤患者救治、降低物质使用和创伤再犯率的重要机会。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Despite recommendations to screen all injured patients for substance use, single-center studies have reported underscreening. This study sought to determine if there was significant practice variability in adoption of alcohol and drug screening of injured patients among hospitals participating in the Trauma Quality Improvement Program.
METHODS: This was a retrospective observational cross-sectional study of trauma patients 18 years or older in Trauma Quality Improvement Program 2017-2018. Hierarchical multivariable logistic regression modeled the odds of screening for alcohol and drugs via blood/urine test while controlling for patient and hospital variables. We identified statistically significant high and low-screening hospitals based on hospitals' estimated random intercepts and associated confidence intervals (CIs).
RESULTS: Of 1,282,111 patients at 744 hospitals, 619,423 (48.3%) were screened for alcohol, and 388,732 (30.3%) were screened for drugs. Hospital-level alcohol screening rates ranged from 0.8% to 99.7%, with a mean rate of 42.4% (SD, 25.1%). Hospital-level drug screening rates ranged from 0.2% to 99.9% (mean, 27.1%; SD, 20.2%). A total of 37.1% (95% CI, 34.7-39.6%) of variance in alcohol screening and 31.5% (95% CI, 29.2-33.9%) of variance in drug screening were at the hospital level. Level I/II trauma centers had higher adjusted odds of alcohol screening (adjusted odds ratio [aOR], 1.31; 95% CI, 1.22-1.41) and drug screening (aOR, 1.16; 95% CI, 1.08-1.25) than Level III and nontrauma centers. We found 297 low-screening and 307 high-screening hospitals in alcohol after adjusting for patient and hospital variables. There were 298 low-screening and 298 high-screening hospitals for drugs.
CONCLUSION: Overall rates of recommended alcohol and drug screening of injured patients were low and varied significantly between hospitals. These results underscore an important opportunity to improve the care of injured patients and reduce rates of substance use and trauma recidivism.
LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level III.
参考来源
- Silver CM, Visenio MR, Thomas AC, et al. Hospital variability in adoption of alcohol and drug screening in adult trauma patients. J Trauma Acute Care Surg. 2023. PMID: 36801898. doi:10.1097/TA.0000000000003928
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。